Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-05

Clinical Trial Update: Highly Purified Menotropin (HP-hMG) Versus Recombinant FSH (rFSH) Plus Recombinant LH (rLH) in Intrauterine Insemination Cycles in Women ≥35 Years: a Prospective Randomized Trial. [Phase 1]

View source ↗

Summary

Prospective randomized Phase 1 trial comparing Highly Purified Menotropin (HP-hMG) with recombinant FSH plus recombinant LH in intrauterine insemination cycles …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Highly Purified Menotropin (HP-hMG) (menotropin)
  • Recombinant FSH (follitropin alfa) (follitropin alfa)
  • Recombinant LH (lutropin alfa) (lutropin alfa)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Female Infertility | Phase 1 | Status: COMPLETED